Danyong Zhang

Title: Danyong Zhang: Innovator in Pharmaceutical Composition

Introduction

Danyong Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release systems for active ingredients. With a total of two patents to his name, Zhang's work is paving the way for advancements in drug delivery methods.

Latest Patents

Zhang's latest patents include a controlled-release system of active pharmaceutical ingredients and a pharmaceutical composition containing dabigatran etexilate. The controlled-release dosage form features an absorption window in the upper gastrointestinal tract, comprising a controlled-release platform and a retention platform. This innovative system allows for sustained and stable drug release by fixing the retention platform on matching teeth in the oral cavity. His second patent focuses on a pharmaceutical composition that enhances the bioavailability of dabigatran etexilate while reducing absorption variability, thus providing a more stable concentration in plasma and minimizing adverse side effects.

Career Highlights

Danyong Zhang is associated with Shanghai WD Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a commitment to improving drug formulations and delivery systems, which are crucial for patient care and treatment efficacy.

Collaborations

Zhang collaborates with notable colleagues, including Liang Chang Dong and Jingmin Shi, who contribute to his research and development efforts. Their combined expertise enhances the potential for groundbreaking advancements in the pharmaceutical industry.

Conclusion

Danyong Zhang's contributions to pharmaceutical innovations demonstrate his dedication to improving drug delivery systems. His patents reflect a deep understanding of pharmaceutical composition and a commitment to enhancing patient outcomes.